FDA Bioequivalence Standards

Nonfiction, Health & Well Being, Medical, Specialties, Pharmacy, Science & Nature, Technology, Engineering, Chemical & Biochemical
Cover of the book FDA Bioequivalence Standards by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781493912520
Publisher: Springer New York Publication: September 5, 2014
Imprint: Springer Language: English
Author:
ISBN: 9781493912520
Publisher: Springer New York
Publication: September 5, 2014
Imprint: Springer
Language: English

This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, Biopharmaceutics Drug Disposition Classification System, bioequivalence modeling/simulation and best practices in bioanalysis. It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs, narrow therapeutic index drugs, liposomes, locally acting gastrointestinal drug products, topical products and nasal and inhalation products.

FDA Bioequivalence Standards is written by FDA regulatory scientists who develop regulatory policies and conduct regulatory assessment of bioequivalence. As such, both practical case studies and fundamental science are highlighted in these chapters.The book is a valuable resource for scientists who work in the pharmaceutical industry, regulatory agencies and academia as well as undergraduate and graduate students looking to expand their knowledge about bioequivalence standards.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, Biopharmaceutics Drug Disposition Classification System, bioequivalence modeling/simulation and best practices in bioanalysis. It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs, narrow therapeutic index drugs, liposomes, locally acting gastrointestinal drug products, topical products and nasal and inhalation products.

FDA Bioequivalence Standards is written by FDA regulatory scientists who develop regulatory policies and conduct regulatory assessment of bioequivalence. As such, both practical case studies and fundamental science are highlighted in these chapters.The book is a valuable resource for scientists who work in the pharmaceutical industry, regulatory agencies and academia as well as undergraduate and graduate students looking to expand their knowledge about bioequivalence standards.

More books from Springer New York

Cover of the book Neonatal Anesthesia by
Cover of the book Biomechanics of the Human Body by
Cover of the book Selected Topics in Micro/Nano-robotics for Biomedical Applications by
Cover of the book Quadratic Diophantine Equations by
Cover of the book Pediatric Sedation Outside of the Operating Room by
Cover of the book Grid Integration and Dynamic Impact of Wind Energy by
Cover of the book Turbo Decoder Architecture for Beyond-4G Applications by
Cover of the book Subunit Vaccine Delivery by
Cover of the book Teaching Mindfulness by
Cover of the book Stress and Women Physicians by
Cover of the book Handbook of Behavior, Food and Nutrition by
Cover of the book Designs for Clinical Trials by
Cover of the book The Bioarchaeology of Space and Place by
Cover of the book The Challenge of CMC Regulatory Compliance for Biopharmaceuticals by
Cover of the book Aided Augmentative Communication for Individuals with Autism Spectrum Disorders by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy